PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1454023
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1454023
According to Stratistics MRC, the Global Pharmacy Automation Devices Market is accounted for $6.15 billion in 2023 and is expected to reach $13.5 billion by 2030 growing at a CAGR of 11.9% during the forecast period. Pharmacy automation devices streamline medication dispensing, improving efficiency and reducing errors in healthcare settings. These advanced systems, such as robotic dispensers and automated pill packaging machines, handle tasks like counting, labeling, and organizing medications. By automating routine processes, these devices enhance accuracy, minimize manual labor, and enhance patient safety. Pharmacy automation devices contribute to a more streamlined and error-resistant medication distribution process, ultimately benefiting both healthcare providers and patients.
Increasing medication errors
The escalating concerns and consequences of medication errors have propelled the demand for Pharmacy Automation Devices. As these errors pose significant risks to patient safety, there is a pressing need to enhance accuracy in prescription dispensing. Automation not only minimizes human errors but also improves workflow efficiency, ensuring precise medication management. Furthermore, the pharmaceutical industry's increasing reliance on automation technologies reflects a strategic response to the imperative of patient safety, thereby fostering the expansion of the market.
High initial investment
Smaller pharmacies and healthcare facilities with constrained budgets may find it financially challenging to invest in these systems. This financial barrier inhibits widespread adoption, limiting the potential benefits of improved efficiency and reduced errors. The disparity in access to automation technology exacerbates healthcare inequalities, hindering smaller players from keeping pace with larger institutions. As a result, the overall impact of high initial investment acts as a restricting factor, impeding the broader integration of Pharmacy Automation Devices
Rising healthcare expenditure
Faced with the need for operational efficiency and cost-effectiveness, healthcare providers increasingly adopt automation solutions. Pharmacy automation devices address this demand by streamlining processes, reducing labor costs, and enhancing workflow efficiency. As healthcare budgets grow, the industry's inclination toward automation technologies intensifies, making these devices indispensable in optimizing pharmacy operations. This symbiotic relationship between rising healthcare expenditure and the adoption of automation underscores the pivotal role these devices play in healthcare management.
Cybersecurity and data privacy challenges
Concerns over the protection of sensitive patient information deter healthcare providers from embracing automation solutions. The potential for data breaches compromises patient confidentiality and undermines trust in automated systems. Addressing these challenges requires substantial investments in robust cybersecurity measures, diverting resources from core healthcare functions.
Covid-19 Impact
The increased demand for healthcare services, coupled with the need for contactless operations and social distancing, has underscored the importance of automation. Pharmacies seek to enhance efficiency, reduce human touchpoints, and ensure uninterrupted medication dispensing during crises. This surge in demand for automation technologies, including robotics and AI-driven solutions, reflects a paradigm shift in the pharmaceutical landscape.
The packaging & labeling systems segment is expected to be the largest during the forecast period
The packaging & labeling systems segment is estimated to have a lucrative growth, due to efficient and accurate packaging, coupled with advanced labeling solutions, enhances medication safety and adherence. Automation in these processes reduces errors, ensuring the right medication reaches the patient. Moreover, integration of smart packaging technologies facilitates real-time tracking and monitoring driving the growth of the market.
The automated dispensing systems (ADS) segment is expected to have the highest CAGR during the forecast period
The automated dispensing systems (ADS) segment is anticipated to witness the highest CAGR growth during the forecast period. By automating the drug dispensing process, ADS improves operational efficiency, ensuring timely and precise medication delivery. The integration of ADS with electronic health records (EHR) further optimizes patient care and pharmacy management. Thus, the demand for pharmacy automation devices surges as healthcare providers recognize the transformative benefits of ADS in enhancing patient safety, reducing manual errors, and improving overall pharmacy operations.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the rising healthcare infrastructure development, increased healthcare spending, and a growing aging population. Countries like China, Japan, and India are witnessing heightened demand for automation solutions to manage expanding pharmaceutical needs efficiently. Furthermore, government initiatives, technological advancements, and the need for operational efficiency contribute to the region's flourishing pharmacy automation market
North America is projected to have the highest CAGR over the forecast period, owing to factors like stringent regulatory standards, technological advancements, and the imperative to reduce medication errors. The region, encompassing the United States and Canada, witnesses a significant drive toward pharmacy automation to enhance patient safety and optimize healthcare workflows. With a focus on improving overall efficiency and compliance with regulatory requirements, North America's pharmacy automation sector continues to evolve as an essential component of advanced healthcare delivery systems.
Key players in the market
Some of the key players in the Pharmacy Automation Devices Market include Accu-Chart Plus Healthcare Systems, Inc., Aesynt, Inc, Amerisource Bergen Corporation, Baxter, Cerner Oracle, Deenova S.R.L, Forhealth Technologies, Fulcrum Pharmacy Management, Inc., Health Robotics S.R.L., ARxIUM, Kirby Lester, McKesson Corporation, Medacist Solutions Group, LLC, Pearson Medical Technologies, Pyxis Corporation, Scriptpro LLC, Talyst, LLC, Touchpoint Medical and Yuyama Co. Ltd/Yuyama MFG Co. Ltd
In February 2024, Cencora's formularydecisions launches payer resource for cell and gene therapy products. Through this CGT resource, registered healthcare payers which collectively represent more than 269 million covered lives will have access to a detailed overview of the CGT landscape and product-based information.
In November 2023, Baxter Issues Urgent Medical Device correction for novum IQ syringe infusion pump due to potential impact of downstream occlusions on infusion volume. The correction is due to the potential for an incomplete infusion following one or more downstream occlusion alarms. Baxter notified impacted customers in October and is developing a software upgrade to resolve the issue.
In November 2023, The Baxter International Foundation and UNICEF Partner to Expand Access to Safe Water and Sanitation in Egypt. This program is designed to deliver prevention-focused, climate-resilient water, sanitation and hygiene (WASH) services for families and children in Egypt
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.